Avia Pharma has completed the acquisition of Neubourg Skin Care GmbH (“Neubourg”), a leading German dermatology company, specialized in skin, foot and nail care. Through the acquisition, Avia adds a strong dermatology brand portfolio in Germany.
During January, Avia Pharma welcomed Impilo AB as a new owner and partner to the co-founders. Impilo is a Nordic investment company focused on long-term investments in sustainable healthcare companies. The partnership with Impilo will allow Avia to execute on its strategy and ambition of building a leading Northern European OTC / Rx platform through organic and inorganic growth.
Avia Pharma Holding AB (“Avia” or the “Company”) has completed the acquisition of Neubourg Skin Care GmbH (“Neubourg”), a leading German dermatology company, specialized in skin, foot and nail care.
During January, Avia Pharma Holding AB, welcomed Impilo AB as a new owner and partner to the co-founders. Impilo is a Nordic investment company focused on long-term investments in sustainable healthcare companies. The partnership with Impilo will allow Avia to execute on its strategy and ambition of building a leading Northern European OTC / Rx platform.
Avia Pharma has today completed the acquisition of finish pharmaceutical company Decem Pharma.
I dag uppmärksammas den vanligaste och mycket smärtsamma formen av inflammatorisk ledsjukdom – gikt. Ledsjukdomen drabbar 2% av Sveriges befolkning och så mycket som 7% av alla män i 75-års ålder. I takt med bland annat ändrade levnadsvanor och en åldrande befolkning kommer antalet som insjuknar fortsätta att öka men kunskaperna kring både diagnos och behandling är oroväckande låga.